Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by A Larionov
Sequential Changes in Gene Expression Profiles in Breast Cancers During Treatment With the Aromatase Inhibitor, Letrozole
Pharmacogenomics Journal
Molecular Medicine
Genetics
Pharmacology
Related publications
Letrozole (CGS 20267), a New Oral Aromatase Inhibitor for the Treatment of Advanced Breast Cancer in Postmenopausal Patients
Acta Oncologica
Nuclear Medicine
Radiology
Hematology
Oncology
Medicine
Imaging
Profiles of miRNAs Matched to Biology in Aromatase Inhibitor Resistant Breast Cancer
Oncotarget
Oncology
LRG1 mRNA Expression in Breast Cancer Associates With PIK3CA Genotype and With Aromatase Inhibitor Therapy Outcome
Molecular Oncology
Cancer Research
Medicine
Oncology
Genetics
Molecular Medicine
Dynamic Changes of Gene Expression Profiles During Postnatal Development of the Heart in Mice
Heart
Cardiovascular Medicine
Cardiology
Deficiencies in Immunoassay Methods Used to Monitor Serum Estradiol Levels During Aromatase Inhibitor Treatment in Postmenopausal Breast Cancer Patients
SpringerPlus
Multidisciplinary
Anastrozole as Aromatase Inhibitor – New Approaches to Breast Cancer Treatment in Postmenopausal Women
Nowotwory
Cancer Research
Oncology
Loss of Heterozygosity and Its Correlation With Expression Profiles in Subclasses of Invasive Breast Cancers
Cancer Research
Cancer Research
Oncology
Gene Expression Profiles Do Not Consistently Predict the Clinical Treatment Response in Locally Advanced Breast Cancer
Molecular Cancer Therapeutics
Cancer Research
Oncology
The HDAC Inhibitor LBH589 (Panobinostat) Is an Inhibitory Modulator of Aromatase Gene Expression
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
